Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) and Orthofix Medical (NASDAQ:OFIX) Critical Review

Orthofix Medical (NASDAQ:OFIX) and Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, analyst recommendations, earnings, valuation and risk.

Earnings and Valuation

This table compares Orthofix Medical and Senseonics Holdings, Inc. Common Stock”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Orthofix Medical	$822.31 million	0.48	-$92.19 million	($1.54)	-6.28
Senseonics Holdings, Inc. Common Stock	$35.26 million	11.40	-$69.11 million	($2.23)	-4.31

Senseonics Holdings, Inc. Common Stock has lower revenue, but higher earnings than Orthofix Medical. Orthofix Medical is trading at a lower price-to-earnings ratio than Senseonics Holdings, Inc. Common Stock, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

Orthofix Medical has a beta of 0.68, meaning that its share price is 32% less volatile than the S&P 500. Comparatively, Senseonics Holdings, Inc. Common Stock has a beta of 1.01, meaning that its share price is 1% more volatile than the S&P 500.

Institutional & Insider Ownership

89.8% of Orthofix Medical shares are held by institutional investors. Comparatively, 12.4% of Senseonics Holdings, Inc. Common Stock shares are held by institutional investors. 2.7% of Orthofix Medical shares are held by company insiders. Comparatively, 4.7% of Senseonics Holdings, Inc. Common Stock shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Analyst Ratings

This is a summary of recent ratings for Orthofix Medical and Senseonics Holdings, Inc. Common Stock, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Orthofix Medical	1	1	3	0	2.40
Senseonics Holdings, Inc. Common Stock	1	1	4	0	2.50

Orthofix Medical currently has a consensus price target of $14.75, indicating a potential upside of 52.61%. Senseonics Holdings, Inc. Common Stock has a consensus price target of $17.20, indicating a potential upside of 78.85%. Given Senseonics Holdings, Inc. Common Stock’s stronger consensus rating and higher probable upside, analysts clearly believe Senseonics Holdings, Inc. Common Stock is more favorable than Orthofix Medical.

Profitability

This table compares Orthofix Medical and Senseonics Holdings, Inc. Common Stock’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Orthofix Medical	-7.41%	-14.05%	-7.17%
Senseonics Holdings, Inc. Common Stock	-225.09%	-165.80%	-80.14%

Summary

Senseonics Holdings, Inc. Common Stock beats Orthofix Medical on 8 of the 14 factors compared between the two stocks.

About Orthofix Medical

Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

About Senseonics Holdings, Inc. Common Stock

Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company’s products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.